BGG World and its subsidiary Algae Health Sciences, Inc. expand their state-of-the-art, 100-percent glass tube photobioreactor microalgae farm to support their growing business.
BGG World (BGG; Irvine, CA) and its subsidiary Algae Health Sciences, Inc. (AHS) expand their state-of-the-art, 100-percent glass tube photobioreactor microalgae farm to support their growing business.
“We’ve seen outstanding increases in our astaxanthin business in recent years as brand owners around the world have come to understand BGG’s value proposition and our unsurpassed quality astaxanthin,” said Chunhua Li, chairman & founder of BGG World, in a press release. “And discerning brands really appreciate that we back up our product quality with human clinical research.”
The company published three peer-reviewed clinical trials on its AstaZine natural astaxanthin last year to support marketing claims and further the science.
The first stage of this expansion is already underway and includes maximization of the farm’s current footprint with additional glass tubing. This stage will increase current capacity by 25 percent in the third quarter of 2020. The second stage is a major expansion that will double the farm’s land area. This acreage is directly adjacent to BGG’s current farm, which will allow for maximum production efficiencies. The second stage is targeted for completion in Q1 of 2021.
“With this new round of investment in our farm, we will secure enough production capacity to support our growth for the next few years and to position BGG as the leading producer worldwide,” Li concluded.